These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 15122789)
1. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. Domínguez A; Bruguera M; Plans P; Costa J; Salleras L J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474 [TBL] [Abstract][Full Text] [Related]
3. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy]. Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam. Richardus JH; Vos D; Veldhuijzen IK; Groen J J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660 [TBL] [Abstract][Full Text] [Related]
5. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G; Belmaker I; Givon-Lavi N; Dagan R Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466 [TBL] [Abstract][Full Text] [Related]
6. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study. Domínguez A; Bruguera M; Plans P; Espuñes J; Costa J; Plasencia A; Salleras L BMC Infect Dis; 2007 Jul; 7():73. PubMed ID: 17610736 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination. Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong. Wong KH; Liu YM; Ng PS; Young BW; Lee SS J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755 [TBL] [Abstract][Full Text] [Related]
9. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839 [TBL] [Abstract][Full Text] [Related]
10. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis a in Lebanon: a changing epidemiological pattern. Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621 [TBL] [Abstract][Full Text] [Related]
12. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination. Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914 [TBL] [Abstract][Full Text] [Related]
13. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation. Costas L; Vilella A; Trilla A; Serrano B; Vera I; Roldán M; Sancho MP; Bayas JM; Gascón J; Costa J J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. Al-Aziz AM; Awad MA East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074 [TBL] [Abstract][Full Text] [Related]
15. Decline of maternal hepatitis a antibodies during the first 2 years of life in infants born in Turkey. Derya A; Necmi A; Emre A; Akgün Y Am J Trop Med Hyg; 2005 Aug; 73(2):457-9. PubMed ID: 16103622 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy. John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469 [TBL] [Abstract][Full Text] [Related]
17. Epidemiologic shift in the prevalence of Hepatitis A virus in Saudi Arabia: a case for routine Hepatitis A vaccination. Almuneef MA; Memish ZA; Balkhy HH; Qahtani M; Alotaibi B; Hajeer A; Qasim L; Al Knawy B Vaccine; 2006 Jul; 24(27-28):5599-603. PubMed ID: 16757065 [TBL] [Abstract][Full Text] [Related]
18. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Joshi N; Yr NK; Kumar A Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625 [TBL] [Abstract][Full Text] [Related]
19. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291 [TBL] [Abstract][Full Text] [Related]
20. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? Anand AC; Nagpal AK; Seth AK; Dhot PS J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]